DE3877529D1 - Herstellung von hoch-gereingtem menschlichen faktor ix sowie anderem plasmaproteinkonzentrat und dessen therapeutische verwendung. - Google Patents
Herstellung von hoch-gereingtem menschlichen faktor ix sowie anderem plasmaproteinkonzentrat und dessen therapeutische verwendung.Info
- Publication number
- DE3877529D1 DE3877529D1 DE8888402643T DE3877529T DE3877529D1 DE 3877529 D1 DE3877529 D1 DE 3877529D1 DE 8888402643 T DE8888402643 T DE 8888402643T DE 3877529 T DE3877529 T DE 3877529T DE 3877529 D1 DE3877529 D1 DE 3877529D1
- Authority
- DE
- Germany
- Prior art keywords
- highly
- manufacture
- therapeutic use
- human factor
- protein concentrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/647—Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8714665A FR2622108B1 (fr) | 1987-10-23 | 1987-10-23 | Preparation de concentres de proconvertine (facteur vii), de facteur antihemophilique b (facteur ix) et d'autres proteines plasmatiques, et leur utilisation therapeutique |
FR8806923A FR2631830B1 (fr) | 1988-05-25 | 1988-05-25 | Concentre de facteur ix de haute purete, sa preparation et son utilisation en therapeutique |
Publications (2)
Publication Number | Publication Date |
---|---|
DE3877529D1 true DE3877529D1 (de) | 1993-02-25 |
DE3877529T2 DE3877529T2 (de) | 1996-11-07 |
Family
ID=26226280
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE3877529T Expired - Lifetime DE3877529T2 (de) | 1987-10-23 | 1988-10-20 | Herstellung von hoch-gereingtem menschlichen Faktor IX sowie anderem Plasmaproteinkonzentrat und dessen therapeutische Verwendung. |
Country Status (8)
Country | Link |
---|---|
US (1) | US5457181A (de) |
EP (1) | EP0317376B2 (de) |
JP (1) | JP2768957B2 (de) |
DE (1) | DE3877529T2 (de) |
DK (1) | DK173859B1 (de) |
ES (1) | ES2045167T5 (de) |
GR (2) | GR3006910T3 (de) |
NO (1) | NO179997C (de) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3914869C1 (de) * | 1989-05-05 | 1990-08-09 | Biotest Pharma Gmbh, 6072 Dreieich, De | |
IE73210B1 (en) * | 1990-01-24 | 1997-05-07 | Warner Lambert Co | Process for the production of thrombin and high purity thrombin preparation thereby obtained |
ES2131504T3 (es) * | 1990-02-20 | 1999-08-01 | Baxter Int | Trombina humana purificada viricamente segura. |
AT402261B (de) * | 1991-01-25 | 1997-03-25 | Immuno Ag | Komplex enthaltend den gerinnungsfaktor ix |
DK0573605T3 (da) | 1991-03-01 | 2001-01-02 | Rhone Poulenc Rorer Int | Fremstilling af faktor IX |
FR2711371B1 (fr) * | 1993-10-18 | 1995-12-29 | Aetsrn | Procédé de préparation d'un concentré d'inter-alpha-trypsine inhibiteur à usage thérapeutique et concentré obtenu. |
DE4342132C1 (de) | 1993-12-10 | 1994-11-03 | Octapharma Ag | Verfahren zur Herstellung virusinaktivierte Vitamin K abhängige Plasmakomponenten sowie Protein C und Protein S enthaltender Mittel durch Membran-Chromatographie |
DE4406515C1 (de) * | 1994-02-28 | 1995-10-19 | Immuno Ag | Verfahren zur Isolierung und Reinigung Vitamin K-abhängiger Proteine |
US6372716B1 (en) | 1994-04-26 | 2002-04-16 | Genetics Institute, Inc. | Formulations for factor IX |
DE4435520A1 (de) * | 1994-10-04 | 1996-04-11 | Immuno Ag | Verfahren zur Trennung von rekombinantem pro-Faktor IX von rekombinantem Faktor IX |
DE19504852C2 (de) * | 1995-02-15 | 2003-01-23 | Octapharma Ag Lachen | Verfahren zur Reinigung Vitamin K-abhängiger Gerinnungsfaktoren durch Affinitäts-Chromatographie |
DE19506633A1 (de) * | 1995-02-25 | 1996-08-29 | Octapharma Ag | Verfahren zur Herstellung von Faktor IX aus biologischen Quellen |
US5714583A (en) | 1995-06-07 | 1998-02-03 | Genetics Institute, Inc. | Factor IX purification methods |
US5770700A (en) * | 1996-01-25 | 1998-06-23 | Genetics Institute, Inc. | Liquid factor IX formulations |
ES2127695B1 (es) * | 1997-02-14 | 2000-03-16 | Grifols Grupo Sa | Procedimiento para la reduccion del contenido de factor plaquetar 4 en proteinas plasmaticas que poseen afinidad a heparina. |
AT407484B (de) * | 1997-11-12 | 2001-03-26 | Bio Prod & Bio Eng Ag | Arzneimittel zur förderung der wundheilung |
HUP0402315A3 (en) | 2001-12-21 | 2009-03-30 | Novo Nordisk Healthcare Ag | Liquid composition of factor vii polypeptides |
US20040009918A1 (en) * | 2002-05-03 | 2004-01-15 | Hanne Nedergaard | Stabilised solid compositions of modified factor VII |
CN1671410B (zh) | 2002-06-21 | 2010-05-12 | 诺和诺德医疗保健公司 | 因子ⅶ多肽的稳定化固体组合物 |
SE0203551D0 (sv) * | 2002-12-02 | 2002-12-02 | Biovitrum Ab | Prothrombin purification |
US20040106779A1 (en) * | 2002-12-03 | 2004-06-03 | Bigler Douglas E. | Modified factor IX preparation |
AT501088A2 (de) * | 2002-12-18 | 2006-06-15 | Bio Prod & Bio Eng Ag | Stabile therapeutische proteine |
US7897734B2 (en) * | 2003-03-26 | 2011-03-01 | Novo Nordisk Healthcare Ag | Method for the production of proteins |
AU2004241698A1 (en) * | 2003-05-23 | 2004-12-02 | Novo Nordisk Health Care Ag | Protein stabilization in solution |
ES2335994T3 (es) * | 2003-07-01 | 2010-04-07 | Novo Nordisk Health Care Ag | Composicion farmaceutica liquida, acuosa de polipeptidos factor vii. |
CA2534028A1 (en) * | 2003-08-14 | 2005-02-24 | Novo Nordisk Health Care Ag | Liquid, aqueous pharmaceutical composition of factor vii polypeptides |
WO2005033140A1 (ja) * | 2003-09-30 | 2005-04-14 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | 高純度血液凝固ix因子調製物およびその精製方法 |
EP3378470A1 (de) * | 2003-12-19 | 2018-09-26 | Novo Nordisk Health Care AG | Stabilisierte zusammensetzungen aus faktor-vii-polypeptiden |
ATE489105T1 (de) * | 2004-03-19 | 2010-12-15 | Baxter Int | Faktor ixa zur behandlung von blutungsstörungen |
KR100667860B1 (ko) * | 2005-10-18 | 2007-01-11 | 주식회사 녹십자 | 고순도 사람 혈액응고 제9인자의 정제 방법 |
CL2007002615A1 (es) * | 2006-09-08 | 2008-04-18 | Wyeth Corp | Metodos para aislar o purificar un producto que comprende poner el producto enlazado en contacto con al menos una solucion de lavado que comprende arginina y luego eluir el producto; y dicho producto. |
WO2008104372A1 (en) * | 2007-02-28 | 2008-09-04 | Baxter International Inc. | Method for the purification of recombinant blood coagulation factor ix enriched in sulfated and/or phosphorylated molecules |
ES2595059T3 (es) | 2007-03-20 | 2016-12-27 | Csl Behring Gmbh | Métodos para la producción a escala industrial de preparados terapéuticos del Factor H del complemento a partir de plasma humano |
EP2640413B1 (de) * | 2010-11-16 | 2019-06-12 | Octapharma AG | Verfahren zur verringerung und/oder entfernung von fxi und fxia aus lösungen mit besagten gerinnungsfaktoren |
EP2652491B1 (de) | 2010-12-15 | 2017-11-29 | Baxalta GmbH | Eluatsammlung mit leitfähigkeitsgradient |
US10378004B2 (en) | 2011-10-14 | 2019-08-13 | Baxalta GmbH | Protein purification by anion exchange chromatography |
US20140206844A1 (en) | 2013-01-18 | 2014-07-24 | Prothera Biologics | Methods for isolating blood products from an inter-alpha inhibitor protein-depleted blood product material |
US9663553B2 (en) | 2014-01-29 | 2017-05-30 | Hemarus Therapeutics Limited | Integrated process for the production of therapeutics (human albumin, immunoglobulins, clotting factor VIII and clotting factor IX) from human plasma |
GB201506113D0 (en) | 2015-04-10 | 2015-05-27 | Ge Healthcare Bio Sciences Ab | Method for chromatography |
GB201506117D0 (en) * | 2015-04-10 | 2015-05-27 | Ge Healthcare Bio Sciences Ab | Method for chromatography |
CN110339209B (zh) * | 2019-07-18 | 2023-06-06 | 上海泰坦科技股份有限公司 | 一种去甲状腺结合蛋白的小牛血清的制备方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2459291C3 (de) * | 1974-12-14 | 1981-06-04 | Biotest-Serum-Institut Gmbh, 6000 Frankfurt | Verfahren zur Herstellung eines antihämophiles Globulin A enthaltenden Konzentrats neben einem Prothrombin- Komplex und einer Lösung von lagerstabilen Serumproteinen |
US4374763A (en) * | 1979-09-17 | 1983-02-22 | Morishita Pharmaceutical Co., Ltd. | Method for producing gamma-globulin for use in intravenous administration and method for producing a pharmaceutical preparation thereof |
US4440679A (en) * | 1980-03-05 | 1984-04-03 | Cutter Laboratories, Inc. | Pasteurized therapeutically active protein compositions |
ATE15489T1 (de) * | 1980-05-27 | 1985-09-15 | Miles Lab | Die blutkoagulation aktivierendes produkt und verfahren zu dessen herstellung. |
AT368883B (de) * | 1980-07-22 | 1982-11-25 | Immuno Ag | Verfahren zur herstellung einer neuen blutgerinnungsfoerdernden praeparation auf basis von humanproteinen |
US4447416A (en) * | 1982-04-28 | 1984-05-08 | American National Red Cross | Plasma protein concentrates of reduced thrombogenicity and their use in clinical replacement therapy |
US4397841A (en) * | 1982-06-28 | 1983-08-09 | Monsanto Company | Production of blood coagulation factor VIII:C |
US4540573A (en) * | 1983-07-14 | 1985-09-10 | New York Blood Center, Inc. | Undenatured virus-free biologically active protein derivatives |
DE3336631A1 (de) * | 1983-10-08 | 1985-04-18 | Behringwerke Ag, 3550 Marburg | Verfahren zur pasteurisierung von plasma oder von konzentraten der blutgerinnungsfaktoren ii, vii, ix und x |
US4777043A (en) * | 1985-12-17 | 1988-10-11 | Genentech, Inc. | Stabilized human tissue plasminogen activator compositions |
EP0229026B1 (de) * | 1986-01-06 | 1995-11-22 | Blood Systems Inc, an Arizona not-for-profit corporation | Therapeutisches Blutprodukt, Mittel und Verfahren zu dessen Erzeugung |
-
1988
- 1988-10-20 DE DE3877529T patent/DE3877529T2/de not_active Expired - Lifetime
- 1988-10-20 ES ES88402643T patent/ES2045167T5/es not_active Expired - Lifetime
- 1988-10-20 EP EP88402643A patent/EP0317376B2/de not_active Expired - Lifetime
- 1988-10-21 NO NO884688A patent/NO179997C/no not_active IP Right Cessation
- 1988-10-21 DK DK198805877A patent/DK173859B1/da not_active IP Right Cessation
- 1988-10-22 JP JP63267004A patent/JP2768957B2/ja not_active Expired - Lifetime
-
1991
- 1991-04-11 US US07/683,109 patent/US5457181A/en not_active Expired - Lifetime
-
1993
- 1993-01-28 GR GR930400157T patent/GR3006910T3/el unknown
-
1996
- 1996-05-13 GR GR960401282T patent/GR3019900T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
GR3019900T3 (en) | 1996-08-31 |
DK587788A (da) | 1989-04-24 |
JP2768957B2 (ja) | 1998-06-25 |
GR3006910T3 (en) | 1993-06-30 |
EP0317376B2 (de) | 1996-04-03 |
EP0317376B1 (de) | 1993-01-13 |
JPH01207239A (ja) | 1989-08-21 |
EP0317376A1 (de) | 1989-05-24 |
DK587788D0 (da) | 1988-10-21 |
ES2045167T3 (es) | 1994-01-16 |
DK173859B1 (da) | 2001-12-31 |
US5457181A (en) | 1995-10-10 |
ES2045167T5 (es) | 1996-07-01 |
DE3877529T2 (de) | 1996-11-07 |
NO179997B (no) | 1996-10-21 |
NO179997C (no) | 1997-01-29 |
NO884688L (no) | 1989-04-24 |
NO884688D0 (no) | 1988-10-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3877529D1 (de) | Herstellung von hoch-gereingtem menschlichen faktor ix sowie anderem plasmaproteinkonzentrat und dessen therapeutische verwendung. | |
DK85786A (da) | Biologisk aktive fragmenter af human antihaemofilisk faktor og fremgangsmaade til fremstilling deraf | |
DE3883985T2 (de) | Ärztliches instrument und dessen herstellung. | |
EE03057B1 (et) | Meetod standardiseeritud, eriti puhta ja teraapiliseks kasutamiseks sobiva inimese von Willebrandi teguri kontsentraadi tööstuslikuks valmistamiseks | |
DK582487A (da) | Smaapartikel aerosolliposom og liposom-laegemiddelkombinationer til medicinsk anvendelse | |
DE3882593D1 (de) | Polypeptid und dessen herstellung. | |
DE68908030T2 (de) | Katheter und Methoden zur Herstellung. | |
NO171269C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive propenonoksimetere og mellomprodukter | |
DE69434777D1 (de) | Verwendung von Relaxin zur Herstellung von therapeutischen Mitteln | |
DE3582594D1 (de) | Proglumid und dessen pharmazeutische zusammensetzungen zur anwendung bei der behandlung von neoplastischen affektionen. | |
DE3682882D1 (de) | Menschliches immunoglobulin-g-fc-region-protein und dessen herstellung. | |
ATE76636T1 (de) | Verfahren zur herstellung von benzoesaeure und ihren salzen. | |
ATE45675T1 (de) | Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen. | |
AU2135988A (en) | Benzopyridazinone and pyridopyridazinone compounds and their use in the treatment of congestive heart failure | |
ATE142503T1 (de) | Arzneimittelzubereitung bei der behandlung von tonsillitis | |
ATE84543T1 (de) | Herstellung von hoch-gereingtem menschlichen faktor ix sowie anderem plasmaproteinkonzentrat und dessen therapeutische verwendung. | |
NO892506D0 (no) | Kloning og ekspresjon av human vevsfaktor. | |
NO172538C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 6-fenoksymetyl-4-hydroksytetrahydropyran-2-oner og 6-tiofen-oksymetyl-4-hydroksytetrahydropyran-2-oner | |
ATE88090T1 (de) | Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom. | |
PT86174A (de) | Homogenes schaft-tiits als zwischenprodukt zur herstellung von menschlichem tiits und dessen verwendung | |
DE68906028D1 (de) | Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom. | |
ATE79759T1 (de) | Kombinationspraeparat zur behandlung von nervenzell-und nervenfasererkrankungen und verletzungen. | |
ATE47400T1 (de) | Gel zur verhuetung der adhaesion von koerpergeweben und dessen herstellung. | |
NO871058D0 (no) | Fremgangsmaate og preparat for behandling av bronkospastiske luftveisykdommer. | |
NO890588L (no) | Kloning og ekspresjon av human vevsfaktor. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8363 | Opposition against the patent | ||
8366 | Restricted maintained after opposition proceedings |